Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Conferences

27 May 2018 - 30 May 2018

ISCAS 2018, Florence, Italy

16 May 2018 - 19 May 2018

21st Annual Meeting ASGCT, Chicago (IL), US

29 Apr 2018 - 03 May 2018

ARVO Annual Meeting, Honolulu, Hawaï, US

06 November 2017

GenSight Biologics to Participate in Multiple Conferences in November

16 October 2017

GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy

04 October 2017

GenSight Biologics to Attend Chardan Gene Therapy Conference

08 May 2017

GenSight Biologics to Present Data on GS010 and GS030 at the Annual Meeting of ARVO

27 April 2017

GenSight Biologics to Present GS010 at the 4th Annual Retinal Cell & Gene Therapy Innovation Summit

20 April 2017

GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Academy of Neurology

19 April 2017

GenSight Biologics to Attend Upcoming Investor Conferences

  • View previous 9 articles
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • View next 9 articles
© 2023 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page